MedPath
HSA Approval

ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIAL

SIN15420P

ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIAL

ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIAL

February 8, 2018

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Regulatory Information

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

J01DE01

cefepime

Manufacturer Information

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Pharma Vision San. Ve Tic. A.Ş.

Qilu Antibiotics Pharmaceutical Co., Ltd. (Blend-Cefepime Hydrochloride (Contains Arginine))

Active Ingredients

Cefepime hydrochloride 2.3784g eqv Cefepime

2g per vial

Cefepime

Documents

Package Inserts

ROXIPIME PI.pdf

Approved: October 23, 2020

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIAL - HSA Approval | MedPath